South Korea
· Delayed Price · Currency is KRW Ilyang Pharmaceutical Co.,Ltd Company Description
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea.
The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines.
It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages.
In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products.
Ilyang Pharmaceutical Co.,Ltd also exports its products. The company was formerly known as Il-Yang Pharm.
Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991.
Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.
| Country | South Korea |
| Founded | 1946 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 637 |
| CEO | Dong-Yeon Kim |
Contact Details
Address: 110, Hagal-ro Yongin, 17096 South Korea | |
| Phone | 82 3 1281 7851 |
| Website | ilyang.co.kr |
Stock Details
| Ticker Symbol | 007570 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7007570005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dong-Yeon Kim | Chief Executive Officer, President and Director |
| Yoo-Suk Jung | Senior MD and Director |
| Kyu-Young Choi | MD and Director |